These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 15772831)
1. Primary hyperoxaluria type 1: is genotyping clinically helpful? Leumann E; Hoppe B Pediatr Nephrol; 2005 May; 20(5):555-7. PubMed ID: 15772831 [TBL] [Abstract][Full Text] [Related]
2. [From gene to disease; primary hyperoxaluria type I caused by mutations in the AGXT gene]. van Woerden CS; Groothof JW; Wanders RJ; Waterham HR; Wijburg FR Ned Tijdschr Geneeskd; 2006 Jul; 150(30):1669-72. PubMed ID: 16922352 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias. Rumsby G; Williams E; Coulter-Mackie M Kidney Int; 2004 Sep; 66(3):959-63. PubMed ID: 15327387 [TBL] [Abstract][Full Text] [Related]
4. Clinical implications of mutation analysis in primary hyperoxaluria type 1. van Woerden CS; Groothoff JW; Wijburg FA; Annink C; Wanders RJ; Waterham HR Kidney Int; 2004 Aug; 66(2):746-52. PubMed ID: 15253729 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis. Monico CG; Rossetti S; Schwanz HA; Olson JB; Lundquist PA; Dawson DB; Harris PC; Milliner DS J Am Soc Nephrol; 2007 Jun; 18(6):1905-14. PubMed ID: 17460142 [TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of the AGXT gene in patients suspected with hyperoxaluria type 1 and three novel mutations from Turkey. Isiyel E; Ezgu SA; Caliskan S; Akman S; Akil I; Tabel Y; Akinci N; Ozdogan EB; Ozel A; Eroglu FK; Ezgu FS Mol Genet Metab; 2016 Dec; 119(4):311-316. PubMed ID: 27915025 [TBL] [Abstract][Full Text] [Related]
7. Mutation spectrum of primary hyperoxaluria type 1 in Tunisia: implication for diagnosis in North Africa. Nagara M; Tiar A; Ben Halim N; Ben Rhouma F; Messaoud O; Bouyacoub Y; Kefi R; Hassayoun S; Zouari N; Ben Ammar MS; Abdelhak S; Chemli J Gene; 2013 Sep; 527(1):316-20. PubMed ID: 23810941 [TBL] [Abstract][Full Text] [Related]
8. Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay. Fargue S; Knight J; Holmes RP; Rumsby G; Danpure CJ Biochim Biophys Acta; 2016 Jun; 1862(6):1055-62. PubMed ID: 26854734 [TBL] [Abstract][Full Text] [Related]
9. Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene. Williams EL; Acquaviva C; Amoroso A; Chevalier F; Coulter-Mackie M; Monico CG; Giachino D; Owen T; Robbiano A; Salido E; Waterham H; Rumsby G Hum Mutat; 2009 Jun; 30(6):910-7. PubMed ID: 19479957 [TBL] [Abstract][Full Text] [Related]
10. Identification of compound heterozygous patients with primary hyperoxaluria type 1: clinical evaluations and in silico investigations. Kanoun H; Jarraya F; Maalej B; Lahiani A; Mahfoudh H; Makni F; Hachicha J; Fakhfakh F BMC Nephrol; 2017 Oct; 18(1):303. PubMed ID: 28969594 [TBL] [Abstract][Full Text] [Related]
11. A double mutation in AGXT gene in families with primary hyperoxaluria type 1. Kanoun H; Jarraya F; Hadj Salem I; Mahfoudh H; Chaabouni Y; Makni F; Hachicha J; Fakhfakh F Gene; 2013 Dec; 531(2):451-6. PubMed ID: 24012869 [TBL] [Abstract][Full Text] [Related]
13. Selected exonic sequencing of the AGXT gene provides a genetic diagnosis in 50% of patients with primary hyperoxaluria type 1. Williams E; Rumsby G Clin Chem; 2007 Jul; 53(7):1216-21. PubMed ID: 17495019 [TBL] [Abstract][Full Text] [Related]
14. Mutational Analysis of Agxt in Tunisian Population with Primary Hyperoxaluria Type 1. M'dimegh S; Omezzine A; M'barek I; Moussa A; Mabrouk S; Kaarout H; Souche G; Chemli J; Aloui S; Aquaviva-Bourdain C; Achour A; Abroug S; Bouslama A Ann Hum Genet; 2017 Jan; 81(1):1-10. PubMed ID: 27935012 [TBL] [Abstract][Full Text] [Related]
15. Genetic heterogeneity in primary hyperoxaluria type 1: impact on diagnosis. Coulter-Mackie MB; Rumsby G Mol Genet Metab; 2004; 83(1-2):38-46. PubMed ID: 15464418 [TBL] [Abstract][Full Text] [Related]
16. Updated genetic testing of Italian patients referred with a clinical diagnosis of primary hyperoxaluria. Pelle A; Cuccurullo A; Mancini C; Sebastiano R; Stallone G; Negrisolo S; Benetti E; Peruzzi L; Petrarulo M; De Marchi M; Marangella M; Amoroso A; Giachino D; Mandrile G J Nephrol; 2017 Apr; 30(2):219-225. PubMed ID: 26946417 [TBL] [Abstract][Full Text] [Related]
17. Mutation-based diagnostic testing for primary hyperoxaluria type 1: survey of results. Coulter-Mackie MB; Lian Q; Applegarth DA; Toone J; Waters PJ; Vallance H Clin Biochem; 2008 May; 41(7-8):598-602. PubMed ID: 18282470 [TBL] [Abstract][Full Text] [Related]
18. A novel mutation in the AGXT gene causing primary hyperoxaluria type I: genotype-phenotype correlation. M'Dimegh S; Aquaviva-Bourdain C; Omezzine A; M'Barek I; Souche G; Zellama D; Abidi K; Achour A; Gargah T; Abroug S; Bouslama A J Genet; 2016 Sep; 95(3):659-66. PubMed ID: 27659337 [TBL] [Abstract][Full Text] [Related]
19. Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome. Harambat J; Fargue S; Acquaviva C; Gagnadoux MF; Janssen F; Liutkus A; Mourani C; Macher MA; Abramowicz D; Legendre C; Durrbach A; Tsimaratos M; Nivet H; Girardin E; Schott AM; Rolland MO; Cochat P Kidney Int; 2010 Mar; 77(5):443-9. PubMed ID: 20016466 [TBL] [Abstract][Full Text] [Related]
20. AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria. Amoroso A; Pirulli D; Florian F; Puzzer D; Boniotto M; Crovella S; Zezlina S; Spanò A; Mazzola G; Savoldi S; Ferrettini C; Berutti S; Petrarulo M; Marangella M J Am Soc Nephrol; 2001 Oct; 12(10):2072-2079. PubMed ID: 11562405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]